HUMANA INC (HUM) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue contracted from $25.29B (period ending 2007-12-31) to $5.83B (period ending 2025-12-31) — a -7.8% annual pace across 18 year(s) of filed history.
- Net margin expanded from 3.3% to 20.4% over that same span.
- Across 54 tracked quarters, the strongest was $14.01B (quarter ending 2016-06-30) and the weakest was $223.0M (quarter ending 2017-09-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $5.83B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Operating income | $2.70B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Net income | $1.19B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Diluted EPS | $9.84 | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Total assets | $48.91B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Total liabilities | $31.17B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Cash & equivalents | $4.20B | 2025-12-31 | 10-K | 0000049071-26-000009 |
| Operating cash flow | $921.0M | 2025-12-31 | 10-K | 0000049071-26-000009 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $1.68B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Operating income | $1.75B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Net income | $1.19B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Diluted EPS | $9.83 | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Total assets | $55.28B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Total liabilities | $36.63B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Cash & equivalents | $4.95B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
| Operating cash flow | $1.25B | 2026-03-31 | 10-Q | 0000049071-26-000023 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Humana Inc. (HUM) operates primarily in the health insurance sector, with a significant focus on Medicare Advantage plans. The company’s scale is substantial, as evidenced by its total assets of $55.28 billion as of the most recent quarter and $48.91 billion as of the latest annual report. However, the mix of the business has shifted dramatically over the years, with revenue plummeting from $25.29 billion in 2007 to $5.83 billion in 2025, reflecting a -7.8% annual contraction over an 18-year period. This trend underscores a transformation from a larger, more diversified entity to a more concentrated health insurance provider.
The multi-year trajectory reveals not only the revenue decline but also an expansion in net margin from 3.3% to 20.4%. This improvement in profitability suggests that despite shrinking revenues, Humana has become more efficient in converting sales into net income. The most recent quarterly figures ($1.68 billion in revenue and $1.19 billion in net income) continue this pattern of lower revenues but higher margins compared to earlier periods.
In the upcoming filings, readers should monitor how Humana manages its shrinking revenue base while maintaining or improving profitability. The company’s ability to sustain positive net income amidst declining revenues will be crucial in assessing its long-term viability and strategic execution within a competitive health insurance landscape. Additionally, the fluctuation in quarterly performance, with the strongest quarter at $14.01 billion and weakest at $223.0 million, indicates potential seasonality or operational efficiencies that warrant further investigation in future disclosures.
Source: SEC EDGAR company facts for CIK 0000049071 · filings index